Previous Close | 1.95 |
1-Year Change | 427.03% |
6-Months Change | 204.69% |
3-Months Change | 126.74% |
Moving Avg (50d) | 1.3905 |
Moving Avg (200d) | 0.8563 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 345.5M |
Beta (3-Years) | 1.68 |
Revenue Growth (ttm) | 79.75% |
Net Profit Margin (ttm) | -123.89% |
Return On Assets (ttm) | -113.58% |
EPS (ttm) | -1.45 |
PE Ratio (ttm) | -1.34 |
Dividend Yield | % |
Asset Description: | Sangamo Therapeutics, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-10-28 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
1.911 | 1.853 | 1.814 | 1.755 | 1.658 | 1.56 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.